CellWell record HH-102435
Efficacy of reticulocyte hemoglobin equivalent-guided versus transferrin saturation-guided iron supplement protocol in hemodialysis patients: A cluster randomized controlled trial
Chalermchon Suttaluang
2026
In plain language
In a trial of 138 hemodialysis patients, guiding iron dosing by a reticulocyte hemoglobin measure worked as well as transferrin-saturation guidance for reducing erythropoietin resistance, while using significantly less iron.
- Evidence
- Emerging
Cite this record: https://thecellwell.org/studies/HH-102435
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.